Many with lupus at high risk for adverse reactions to pneumocystis pneumonia drug
New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions ...
Nov 6, 2020
0
1